Stemedica Cell Technologies announced at a media conference September 13th that it has established a partnership with Hospital Angeles -Tijuana, part of Grupo Angeles Servicios de Salud, the largest hospital chain in Mexico. The partnership will provide adult stem cell treatments to patients with a wide variety of medical conditions including Alzheimer's, Parkinson's, Multiple Sclerosis, Muscular Dystrophy, Stroke, Ischemic Brain Trauma's, Spinal Cord Injuries, Diabetes, Macular Degeneration, and Diabetic Retinopathy, as well as skin, scar and bone regeneration.

At the conference, Maynard Howe, Ph.D, CEO and Vice-Chairman of Stemedica, explained that Stemedica was formed when a relative was seriously injured in a car accident. The family began to explore various treatments for spinal cord injuries and discovered that Russia had been developing stem cell technology for over 30 years. The relative, who was a quadriplegic, has undergone two treatments in Russia. Since then, she has regained the use of her upper body and is now learning to walk again, as she demonstrated for the audience at the media conference.

According to Dr. Howe, the partnership with Hospital Angeles - Tijuana is an exciting opportunity to work with the leading hospital chain in Mexico. "Hospital Angeles is a state of the art facility providing the highest level of care."

At the conference, Dr. Cesar Amescua, the hospital's medical director, gave an in-depth presentation regarding patient treatments using adult stem cells. Dr. Amescua said "We expect to demonstrate the safety and efficacy of adult stem cell treatments in patients through use of Stemedica's innovative technology."

Stemedica is currently developing relationships with a number of licensed treatment centers, which to date have treated more than 2,000 patients in Moscow, Seoul, Paris, and Lausanne.